HCN1 and depressive symptom measurement: From the data of this study, we found that decreasing the expression of HCN1 in the animal model of PTSD alleviates PTSD-like symptoms, reducing depression-like symptoms and improving spatial learning ability followed by an upregulation of BDNF–mTOR signaling pathways in the PFC and Hip.